 |
 |
 |
 |
 |
|
| pleasingly plump , conditions, american surgical association, video, protein calorie malnutrition, busty plump , fat ugly girls , hep, inc., pegasys, symptoms, 1 fat girls , omega minus three fatty acids , | 15 Study start: January 2004Last pegasus follow-up: August 2005 Study population: 30 patients will be included who meet all the following criteria: ALT > 2 times normal range; liver histology revealing NASH (type 2-4), without cirrhosis; clinical characteristics of the metabolic syndrome as pegasus defined by the NCEP, but no overt diabetes; negative work-up for other causes of liver diseases including pegasus alcohol intake < 40 g/week. All patients will undergo liver biopsy and only patients with type 2-4 (steatosis + inflammation, or steatosis plus ballooning degeneration, or steatosis plus fibrosis and/or Mallory bodies) but without cirrhosis will be included. |
Best Fat Paysites
|
| Identifier: NCT00247117Health Authority: Israel: Ministry of Health, Jerusalem ClinicalTrials.gov processed this record on 2006-03-17 U.S. National Library of Medicine, Contact NLM Customer ServiceNational Institutes of Health, Department of Health & Human ServicesCopyright, Privacy, Accessibility, Freedom of Information Act HomeSearchListingsResourcesHelpWhat's NewAbout Metformin in Patients With Non-Alcoholic Fatty Liver Disease conditions (NAFLD) conditions This study is currently recruiting patients.Verified by Kaplan Medical Center October 2003 Sponsored by: Kaplan Medical Center Information provided by: Kaplan Medical Center conditions ClinicalTrials.gov Identifier: NCT00247117 Purpose The purpose of this study is to examine the effect of metformin on biochemical and histological findings in NAFLD patients with insulin resistance syndrome. Condition Intervention Liver Diseases Drug: Metformin MedlinePlus related topics: Liver DiseasesGenetics Home Reference related topics: Liver Diseases Study Type: InterventionalStudy Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study Official Title: Study of the Effect of Metformin in Patients With Non-Alcoholic Fatty Liver Disease Further study details as provided by Kaplan Medical Center: Primary Outcomes: histological and biochemical changes Expected Total Enrollment: |
|
Looking for real sex? Find someone now on the
largest sex personals network.FREE signup! Post a FREE erotic ad w/5 photos, flirt in chatrooms, view explicit live Webcams, meet for REAL sex! 30,000 new photos every day! Find SEX now 
|
